NASDAQ
Myriad Genetics, Inc. (MYGN) has a current ratio of 2.49x as of Monday, May 25, 2026. This represents a 21.23% increase compared to its 12-month average of 2.05x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.